Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well pioglitazone hydrochloride works in preventing head and
neck cancer in patients who have oral leukoplakia. Chemoprevention therapy is the use of
certain drugs to try to prevent the development or recurrence of cancer. The use of
pioglitazone hydrochloride may be effective in preventing head and neck cancer.